IRIS
PASTORINO, LORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.548
AS - Asia 1.353
NA - Nord America 750
SA - Sud America 127
AF - Africa 21
OC - Oceania 12
Totale 15.811
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.304
US - Stati Uniti d'America 716
SG - Singapore 564
CN - Cina 373
VN - Vietnam 269
FR - Francia 110
BR - Brasile 72
HK - Hong Kong 41
FI - Finlandia 30
JP - Giappone 28
DE - Germania 27
AR - Argentina 26
GB - Regno Unito 16
CA - Canada 13
CH - Svizzera 13
AU - Australia 12
IN - India 12
MX - Messico 11
BD - Bangladesh 10
IQ - Iraq 10
NL - Olanda 10
CL - Cile 7
ID - Indonesia 7
IE - Irlanda 7
EC - Ecuador 6
UZ - Uzbekistan 5
AT - Austria 4
CO - Colombia 4
RU - Federazione Russa 4
VE - Venezuela 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ES - Italia 3
ET - Etiopia 3
JO - Giordania 3
KR - Corea 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
PK - Pakistan 3
TH - Thailandia 3
UY - Uruguay 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CY - Cipro 2
DZ - Algeria 2
HR - Croazia 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
AL - Albania 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 15.811
Salva come PNG Salva come JPEG
Città #
Genova 7.156
Genoa 3.969
Rapallo 1.151
Vado Ligure 910
San Jose 269
Singapore 238
Ashburn 108
Lauterbourg 104
Ho Chi Minh City 83
Council Bluffs 75
Beijing 69
Hanoi 61
Hong Kong 39
New York 37
Bordighera 27
Helsinki 27
Frankfurt am Main 22
Tokyo 20
Santa Clara 18
Milan 17
Zurich 13
Haiphong 11
São Paulo 11
Tianjin 11
Da Nang 10
Los Angeles 10
Rome 9
Chicago 7
Mexico City 7
Orem 7
Amsterdam 6
Baghdad 6
Dublin 6
London 6
Atlanta 5
Biên Hòa 5
Dallas 5
Hải Dương 5
Rio de Janeiro 5
Bologna 4
Buenos Aires 4
Can Tho 4
Des Moines 4
Houston 4
Montreal 4
Mumbai 4
Quảng Ngãi 4
Addis Ababa 3
Brugherio 3
Buffalo 3
Bắc Ninh 3
Denver 3
Hưng Yên 3
Lappeenranta 3
Marseille 3
Miami 3
Ninh Bình 3
Prague 3
Santiago 3
Vienna 3
Amman 2
Asunción 2
Baku 2
Bari 2
Belgrade 2
Boardman 2
Brantford 2
Brasília 2
Bắc Giang 2
Cairo 2
Cardiff 2
Catania 2
Charlotte 2
Chennai 2
City of London 2
Colombo 2
Cuenca 2
Da Lat 2
Dakar 2
Gravina in Puglia 2
Guangzhou 2
Guayaquil 2
Johannesburg 2
Karbala 2
Manchester 2
Modena 2
Montes Claros 2
Montevideo 2
Muscat 2
New Delhi 2
Nicosia 2
North Bergen 2
Nuremberg 2
Phủ Lý 2
Quận Ba 2
Quận Bình Thạnh 2
Riyadh 2
San José 2
Sydney 2
Tampa 2
Totale 14.696
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 249
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. 230
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 220
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 208
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 208
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 207
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 206
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 206
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 204
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 203
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 200
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 196
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 194
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project. 194
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma 192
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 191
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 190
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 187
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 185
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 184
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 183
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 181
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 181
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. 180
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 178
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 171
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 170
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 168
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 165
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 163
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 160
Genome-wide association study identifies three new melanoma susceptibility loci 160
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 157
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 155
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 153
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 153
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 151
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 150
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 149
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 148
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 148
"Gestione Melanoma" un "database" relazionale per lo studio e l’approfondimento della relazione genotipo/fenotipo e genotipo/ambiente nel melanoma familiare e sporadico 147
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 146
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 145
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 144
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin 144
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 143
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 143
Identification of a SUFU germline mutation in a family with Gorlin syndrome 142
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 141
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 140
A novel PTCH1 gene mutation in a pediatric patient associated multiple keratocystic odontogenic tumors of the jaws and Gorlin-Goltz syndrome 140
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 138
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 137
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 137
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 137
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 137
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 136
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 133
The role of AIRE polymorphisms in melanoma. 131
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations 131
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 130
Novel MC1R variants in Ligurian melanoma patients and controls 130
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria 129
Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression 128
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. 127
Analysis of Cultured Human Melanocytes Based on Polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P Loci. 126
Analisi molecolare del gene PTCH nella Sindrome di Gorlin (Carcinoma Nevo Basocellulare NBCCS) 125
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: A pooled analysis from the M-SKIP project 124
INK4/ARF germline alterations in pancreatic cancer patients 123
CDKN2A mutation distribution in ligurian sporadic melanoma according to age at diagnosis 122
Absence of melanocortin 1 receptor variants in Ligurian Gly101trp families 122
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations 122
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 122
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 122
Analisi della sequenza codificante e regolatrice del gene di suscettibilità al melanoma CDKN2A in 62 famiglie 119
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 118
Correlation between NF-kB/GM-CSF expression and functional status of the p16 melanoma susceptibility gene 113
Analisi di mutazioni del gene PTCH nella sindrome di Gorlin 110
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 110
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 110
Correlazione tra l’espressione di NF-KB e lo stato funzionale del gene di suscettibilità al melanoma familiare CDKN2A (p16ink4) 108
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 108
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 107
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 105
Frequency of 3’UTR polymorphisms in the CDKN2A gene in familial and non-familial Ligurian melanoma patients 105
Diagnostic and pathogenetic role of cafe-au-lait macules in nevoid basal cell carcinoma syndrome 104
Clinical utility gene card for: Gorlin syndrome 104
Varianti polimorfiche del gene MC1R (melanocortin receptor 1): Analisi in pazienti Liguri affetti da melanoma e negativi per mutazioni nei geni CDKN2A e CDK4 103
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy 101
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 101
Erratum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma (Nature (2011) 480:94-98 doi:10.1038/nature10539) 99
Proteomic analysis of PTCH1 +/- Fibroblast lysate and conditioned culture media isolated from the skin of healthy subjects and nevoid basal cell carcinoma syndrome patients 97
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 97
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 95
INK4/ARF germline mutations and additional neoplasia in pancreatic cancer patients and their families 94
Germline mutations of the PTCH gene in Italian patients with Nevoid Basal Cell Carcinoma Syndrome 91
Prevalence of CDKN2A gene mutations in patients with early-onset sporadic melanoma 91
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants 91
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. 90
Totale 14.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.515
article - articoli 44.287
book - libri 0
conference - conferenze 7.917
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 311
Totale 105.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 0 0 0 0 103 69 65
2021/20221.312 30 103 83 178 53 85 94 308 70 111 50 147
2022/20231.399 154 117 11 156 260 193 10 97 201 12 167 21
2023/2024823 27 95 9 94 47 132 50 56 71 38 54 150
2024/20252.409 95 165 81 184 276 235 256 441 91 101 202 282
2025/20264.078 527 159 527 388 533 385 614 189 364 392 0 0
Totale 16.113